Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Interactions of HIV Protease Inhibitors with a Human Organic Cation Transporter in a Mammalian Expression System

Lei Zhang, Wenche Gorset, Carla B. Washington, Terrence F. Blaschke, Deanna L. Kroetz and Kathleen M. Giacomini
Drug Metabolism and Disposition March 2000, 28 (3) 329-334;
Lei Zhang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wenche Gorset
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carla B. Washington
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Terrence F. Blaschke
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Deanna L. Kroetz
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kathleen M. Giacomini
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Recently, we cloned a human organic cation transporter, hOCT1, which is expressed primarily in the liver. hOCT1 plays an important role in the cellular uptake and elimination of various xenobiotics including therapeutically important drugs. HIV protease inhibitors are a new class of therapeutic agents. The purpose of this study was to elucidate the interactions of HIV protease inhibitors with hOCT1 and to determine whether hOCT1 is involved in the elimination of these compounds. We studied the interactions of HIV protease inhibitors with hOCT1 in a transiently transfected human cell line, HeLa. Uptake studies were carried out 40 h post-transfection using the radiolabeled model organic cation, [14C]tetraethylammonium (TEA), under different experimental conditions. In cis-inhibition studies, all of the HIV protease inhibitors tested, i.e., indinavir (IC50 of 62 μM), nelfinavir (IC50 of 22 μM), ritonavir (IC50 of 5.2 μM), and saquinavir (IC50 of 8.3 μM) inhibited TEA uptake in HeLa cells expressing hOCT1. However, none of the HIV protease inhibitorstrans-stimulated [14C]TEA uptake, suggesting that they are poorly translocated by hOCT1. Nelfinavir, ritonavir, and saquinavir demonstrated an apparent “trans-inhibition” effect. No enhanced uptake of [14C]saquinavir was observed in hOCT1 DNA-transfected cells versus empty vector-transfected cells. These data suggest that HIV protease inhibitors are potent inhibitors, but poor substrates, of hOCT1. Some HIV protease inhibitors may potently inhibit the uptake and elimination of cationic drugs that are substrates for hOCT1, leading to potential drug-drug interactions. Other transporters, e.g., MDR1 and MRP1, in HIV-targeted cells may control the intracellular concentrations of HIV protease inhibitors.

Footnotes

  • Send reprint requests to: Kathleen M. Giacomini, Ph.D., Department of Biopharmaceutical Sciences, University of California San Francisco, 513 Parnassus, S-926, San Francisco, CA 94143-0446. E-mail:kmg{at}itsa.ucsf.edu

  • ↵1 Present address: Metabolism and Pharmacokinetics, Bristol-Myers Squibb Company, Wallingford, Connecticut.

  • ↵2 Present address: Department of Drug Metabolism, Genentech, Inc., South San Francisco, California.

  • This study was supported by National Institutes of Health Grants GM-57656 and GM-36780 (K.M.G.) and HL-53994 (D.L.K.). Lei Zhang was supported in part by the University of California San Francisco Chancellor's Graduate Research Fellowship.

  • Abbreviations used are::
    TEA
    tetraethylammonium
    RT-PCR
    reverse transcriptase-polymerase chain reaction
    Cmax
    maximum plasma concentration
    CYP
    cytochrome P-450
    hOCT1
    human organic cation transporter 1
    P-gp
    P-glycoprotein
    • Received May 7, 1999.
    • Accepted November 15, 1999.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

 

DMD articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 28 (3)
Drug Metabolism and Disposition
Vol. 28, Issue 3
1 Mar 2000
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Interactions of HIV Protease Inhibitors with a Human Organic Cation Transporter in a Mammalian Expression System
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Interactions of HIV Protease Inhibitors with a Human Organic Cation Transporter in a Mammalian Expression System

Lei Zhang, Wenche Gorset, Carla B. Washington, Terrence F. Blaschke, Deanna L. Kroetz and Kathleen M. Giacomini
Drug Metabolism and Disposition March 1, 2000, 28 (3) 329-334;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Interactions of HIV Protease Inhibitors with a Human Organic Cation Transporter in a Mammalian Expression System

Lei Zhang, Wenche Gorset, Carla B. Washington, Terrence F. Blaschke, Deanna L. Kroetz and Kathleen M. Giacomini
Drug Metabolism and Disposition March 1, 2000, 28 (3) 329-334;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • AKRs and GUSs in Testosterone Disposition
  • Olanzapine Glucuronidation in Humanized Mice
  • rs2242480 Regulates the Expression of CYP3A4 and CYP3A5
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics